Copenhagen Bioengineering ApS Financials, key figures and credit report
Gross profit -90.6 kDKK FY 2025 -166.1% vs 2024
EBIT - 145.5 kDKK FY 2025 -662.8% vs 2024
Net debt - 628.3 kDKK FY 2025 +12.9% vs 2024
Quick ratio 42.6 FY 2025 +9.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 243.31 | - 484.13 | 187.40 | 136.92 | -90.56 |
| Employee benefit expenses | -47.26 | -66.81 | -28.69 | ||
| Total depreciation | -34.93 | -45.89 | -45.89 | -44.25 | -26.29 |
| EBIT | 208.38 | - 530.02 | 94.26 | 25.86 | - 145.53 |
| Other financial income | 2.53 | 3.57 | 4.87 | 8.92 | 9.30 |
| Other financial expenses | -7.90 | -3.94 | -1.18 | -0.25 | -0.03 |
| Pre-tax profit | 203.00 | - 530.39 | 97.95 | 34.54 | - 136.26 |
| Income taxes | -44.81 | 116.50 | -21.76 | -7.27 | -73.75 |
| Net earnings | 158.19 | - 413.90 | 76.18 | 27.26 | - 210.01 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 289.23 | 243.35 | 197.46 | 153.21 | 126.92 |
| Tangible assets total | 289.23 | 243.35 | 197.46 | 153.21 | 126.92 |
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 8.19 | 8.19 | |||
| Inventories total | 8.19 | 8.19 | |||
| Prepayments and accrued income | 13.09 | ||||
| Current other receivables | 577.09 | 498.96 | 630.03 | 45.10 | 57.35 |
| Current deferred tax assets | 154.99 | 129.02 | 103.75 | 4.00 | |
| Short term receivables total | 577.09 | 653.95 | 759.06 | 161.94 | 61.35 |
| Cash and bank deposits | 560.11 | 120.62 | 64.84 | 721.71 | 628.30 |
| Cash and cash equivalents | 560.11 | 120.62 | 64.84 | 721.71 | 628.30 |
| Balance sheet total (assets) | 1 426.43 | 1 017.92 | 1 021.36 | 1 045.05 | 824.76 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.05 | 50.05 | 50.05 | 50.05 | 50.05 |
| Retained earnings | 1 120.78 | 1 278.97 | 865.08 | 941.26 | 968.52 |
| Profit of the financial year | 158.19 | - 413.90 | 76.18 | 27.26 | - 210.01 |
| Shareholders equity total | 1 329.02 | 915.13 | 991.31 | 1 018.57 | 808.56 |
| Provisions | 13.71 | ||||
| Non-current liabilities total | |||||
| Current trade creditors | 25.00 | 25.76 | 27.00 | 22.50 | 16.20 |
| Short-term deferred tax liabilities | 8.20 | ||||
| Other non-interest bearing current liabilities | 50.49 | 77.03 | 3.05 | 3.98 | |
| Current liabilities total | 83.69 | 102.79 | 30.05 | 26.48 | 16.20 |
| Balance sheet total (liabilities) | 1 426.43 | 1 017.92 | 1 021.36 | 1 045.05 | 824.76 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated